GI
ANIK icon

GAMMA Investing’s Anika Therapeutics ANIK Stock Holding History

GAMMA Investing’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.49K Buy
381
+61
+19% +$1.17K ﹤0.01% 3488
2026
Q2 		$4.68K Buy
320
+31
+11% +$459 ﹤0.01% 3494
2026
Q1 		$4.19K Buy
+289
New +$3.35K ﹤0.01% 3426
2025
Q2 		– Sell
-426
Closed -$6.4K – 3779
2025
Q1 		$6.4K Buy
426
+293
+220% +$4.87K ﹤0.01% 2970
2024
Q4 		$2.19K Sell
133
-101
-43% -$1.99K ﹤0.01% 3195
2024
Q3 		$5.78K Buy
234
+114
+95% +$2.96K ﹤0.01% 2695
2024
Q2 		$3.04K Sell
120
-58
-33% -$1.5K ﹤0.01% 2748
2024
Q1 		$4.52K Hold
178
– – ﹤0.01% 2452
2023
Q4 		$4.19K Buy
+178
New +$3.68K ﹤0.01% 2318

Other funds holding ANIK

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's ANIK Position: Q3 2026 in Review

GAMMA Investing increased its Anika Therapeutics (ANIK) stake by 19% in Q3 2026, buying an estimated $1.17K and bringing the position to 381 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3488.

GAMMA Investing first reported a position in ANIK in Q4 2023 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • GAMMA Investing held 381 shares of Anika Therapeutics worth $7.49K as of Q3 2026.
  • GAMMA Investing bought 61 Anika Therapeutics shares in Q3 2026, an estimated $1.17K.
  • Anika Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3488 holding.
  • GAMMA Investing first reported a position in Anika Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • 7 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.